St. Lukes Hospital of Kansas City — Kansas City, Missouri

St. Lukes Hospital of Kansas City is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

St. Lukes Hospital of Kansas City has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer.

Sponsors: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics).

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Lukes Hospital of Kansas City?

St. Lukes Hospital of Kansas City has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Lukes Hospital of Kansas City conducted?

St. Lukes Hospital of Kansas City has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer.

Is St. Lukes Hospital of Kansas City accredited by Crixeo Health?

St. Lukes Hospital of Kansas City has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Lukes Hospital of Kansas City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.